» Articles » PMID: 27884017

The P53 Family Orchestrates the Regulation of Metabolism: Physiological Regulation and Implications for Cancer Therapy

Overview
Journal Br J Cancer
Specialty Oncology
Date 2016 Nov 25
PMID 27884017
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

The p53 family of transcription factors is essential to counteract tumour formation and progression. Although previously this was exclusively associated with the ability of the p53 family to induce cell cycle arrest and apoptosis, an increasing number of reports have now indisputably demonstrated that the tumour suppressive functions of the p53 family members also rely on their ability to control and regulate cellular metabolism and maintain cellular oxidative homeostasis. Here, we review how each p53 family member, including p63 and p73, controls metabolic pathways in physiological conditions, and how these mechanisms could be exploited to provide anticancer therapeutic opportunities.

Citing Articles

Low Cell Bioenergetic Metabolism Characterizes Chronic Lymphocytic Leukemia Patients with Unfavorable Genetic Factors and with a Better Response to BTK Inhibition.

Mirabilii S, Piedimonte M, Conte E, Mirabilii D, Rossi F, Bomben R Curr Issues Mol Biol. 2024; 46(6):5085-5099.

PMID: 38920977 PMC: 11202558. DOI: 10.3390/cimb46060305.


Does the miR-105-1-Kisspeptin Axis Promote Ovarian Cell Functions?.

Fabova Z, Loncova B, Harrath A, Sirotkin A Reprod Sci. 2024; 31(8):2293-2308.

PMID: 38632222 PMC: 11289008. DOI: 10.1007/s43032-024-01554-3.


The p53 tumor suppressor regulates AKR1B1 expression, a metastasis-promoting gene in breast cancer.

Di Benedetto C, Etichetti C, Cocordano N, Cantoia A, Arel Zalazar E, Bicciato S Front Mol Biosci. 2023; 10:1145279.

PMID: 37780210 PMC: 10538543. DOI: 10.3389/fmolb.2023.1145279.


Preclinical investigations of the efficacy of the glutaminase inhibitor CB-839 alone and in combinations in chronic lymphocytic leukemia.

Timofeeva N, Ayres M, Baran N, Santiago-OFarrill J, Bildik G, Lu Z Front Oncol. 2023; 13:1161254.

PMID: 37228498 PMC: 10203524. DOI: 10.3389/fonc.2023.1161254.


Ameliorative effects of bilirubin on cell culture model of non-alcoholic fatty liver disease.

Vakili O, Borji M, Saffari-Chaleshtori J, Shafiee S Mol Biol Rep. 2023; 50(5):4411-4422.

PMID: 36971910 DOI: 10.1007/s11033-023-08339-y.


References
1.
Tyner S, Venkatachalam S, Choi J, Jones S, Ghebranious N, Igelmann H . p53 mutant mice that display early ageing-associated phenotypes. Nature. 2002; 415(6867):45-53. DOI: 10.1038/415045a. View

2.
Contractor T, Harris C . p53 negatively regulates transcription of the pyruvate dehydrogenase kinase Pdk2. Cancer Res. 2011; 72(2):560-7. DOI: 10.1158/0008-5472.CAN-11-1215. View

3.
Tomasini R, Tsuchihara K, Wilhelm M, Fujitani M, Rufini A, Cheung C . TAp73 knockout shows genomic instability with infertility and tumor suppressor functions. Genes Dev. 2008; 22(19):2677-91. PMC: 2559903. DOI: 10.1101/gad.1695308. View

4.
Linke S, Clarkin K, Di Leonardo A, Tsou A, Wahl G . A reversible, p53-dependent G0/G1 cell cycle arrest induced by ribonucleotide depletion in the absence of detectable DNA damage. Genes Dev. 1996; 10(8):934-47. DOI: 10.1101/gad.10.8.934. View

5.
Yahagi N, Shimano H, Matsuzaka T, Najima Y, Sekiya M, Nakagawa Y . p53 Activation in adipocytes of obese mice. J Biol Chem. 2003; 278(28):25395-400. DOI: 10.1074/jbc.M302364200. View